PEOPLE - Anika Therapeutics (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Anika Therapeutics (Woburn, Massachusetts), a developer, manufacturer and commercialiser of therapeutic products and devices for the repair, protection and healing of bone, cartilage and soft tissue, has announced two appointments. Charles Sherwood, the current president and COO, has had his responsibilities expanded to include CEO. Dr Sherwood, who joined Anika as vice-president of product development in 1998, replaces Douglas Potter, who will continue to serve as CFO until a successor is found. Robert Tellis, who has over 30 years of experience in the healthcare industry, has been appointed as senior vice-president of marketing.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.